{"id":"W2972756983","doi":"10.1007/s12325-019-01086-2","title":"The Design and Rationale of the Trail1 Trial: A Randomized Double-Blind Phase 2 Clinical Trial of Pirfenidone in Rheumatoid Arthritis-Associated Interstitial Lung Disease","year":2019,"lang":"en","type":"article","venue":"Advances in Therapy","topic":"Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":false,"ca_institutions":"McMaster University","funders":"Genentech; Gilead Sciences","keywords":"Medicine; Pirfenidone; Rheumatoid arthritis; Interstitial lung disease; Rheumatology; Internal medicine; Randomized controlled trial; Clinical trial; Physical therapy; Lung; Intensive care medicine; Idiopathic pulmonary fibrosis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01587886,0.004913692,0.00621271,0.001017923,0.002167392,0.002719434,0.001961219,0.005802298,0.01149558],"category_scores_gemma":[0.0129018,0.002693335,0.003248329,0.001027399,0.005102918,0.002494144,0.001103699,0.007248101,0.003101277],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001235895,"about_ca_system_score_gemma":0.004548268,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007280713,"about_ca_topic_score_gemma":0.001403494,"domain_scores_codex":[0.9890267,0.007365237,0.0007777315,0.001244141,0.0007330312,0.0008532925],"domain_scores_gemma":[0.9968961,0.001075589,0.0005914835,0.0003989672,0.0003364533,0.0007013494],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9639367,0.006229806,0.0007105742,0.002729152,0.0009829025,0.0001148846,0.0001480906,0.00106966,0.002374952,0.002764901,0.003665518,0.01527288],"study_design_scores_gemma":[0.9731141,0.02057523,0.0003639652,0.0001163054,0.0003692381,0.00003310004,0.00001884842,0.0004469488,0.0002406689,0.0008114958,0.003876269,0.00003386763],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"protocol","genre_gemma":"protocol","genre_scores_codex":[0.2235123,0.01532061,0.02011395,0.00748711,0.00866296,0.704369,0.006541597,0.0008875558,0.01310499],"genre_scores_gemma":[0.2508252,0.004432971,0.03680216,0.007887778,0.002905503,0.6871528,0.002021222,0.0001701225,0.00780227],"genre_candidate":"protocol","genre_consensus":"protocol","teacher_disagreement_score":0.01587886,"threshold_uncertainty_score":0.08397645,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03812078492113691,"score_gpt":0.3696096718266553,"score_spread":0.3314888869055184,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}